RGLS8429

DRUG2 trials

Sponsors

Regulus Therapeutics Inc.

Conditions

ADPKDAutosomal Dominant Polycystic Kidney DiseaseHealthy VolunteersPolycystic Kidney, Autosomal Dominant

Phase 1

A Study of RGLS8429 in Healthy Volunteers

CompletedNCT05429073

Regulus Therapeutics Inc.Healthy Volunteers

Start: 2022-06-10End: 2022-09-08Updated: 2025-08-27

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

CompletedNCT05521191

Regulus Therapeutics Inc.ADPKD, Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney, Autosomal Dominant

Start: 2022-10-06End: 2025-03-27Updated: 2025-06-03